Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds
An experimental personalized mRNA vaccine in combination with the immunotherapy Keytruda reduced the risk of recurrence or death from melanoma in patients who had already had surgery, Moderna and Merck said Tuesday.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Immunotherapy | Melanoma | Merck | Skin Cancer | Study | Vaccines